EVO Evotec SE Forecast, Technical & Fundamental Analysis

Industry PharmaceuticalsOther

Get AI intraday signals

EVO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EVO
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

EVO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EVO
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

EVO is expected to report earnings to fall 95.87% to -1 cents per share on November 06

Q3'24

Est.

$-0.01

Q2'24

Missed

by $0.26

Q1'24

Est.

$-0.06

Q4'23

Missed

by $0.04

Q3'23

Missed

by $0.09

The last earnings report on August 13 showed earnings per share of -29 cents, missing the estimate of -3 cents. With 116.72K shares outstanding, the current market capitalization sits at 2.77B.

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

N/A

Address

Essener Bogen 7

Phone

+49 40560810

Employees

4952

Web

https://www.evotec.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	23.14	-0.28	-1.20%
GameStop Corp
TSLA	210.60	-3.51	-1.64%
Tesla
SPY	552.08	-11.60	-2.06%
SPDR® S&P 500® ETF Trust
AAPL	222.77	-6.23	-2.72%
Apple
BTC.X	57431.023000	-1681.457000	-2.84%
Bitcoin cryptocurrency

EVO and Stocks

Correlation & Price change

A.I.dvisor tells us that EVO and EBS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVO and EBS's prices will move in lockstep.

Ticker / NAME	Correlation To EVO	1D Price Change %
EVO	100%	-8.49%
EBS - EVO	27% Poorly correlated	-11.07%
ESPR - EVO	25% Poorly correlated	N/A
COLL - EVO	21% Poorly correlated	-2.70%
ZTS - EVO	21% Poorly correlated	+0.04%
INDV - EVO	21% Poorly correlated	-2.64%
More

Groups containing EVO

Correlation & Price change

Ticker / NAME	Correlation To EVO	1D Price Change %
EVO	100%	-8.49%
Pharmaceuticals category (328 stocks)	9% Poorly correlated	+0.11%
Pharmaceuticals: Other category (252 stocks)	7% Poorly correlated	+0.05%